Molecular assembly of clostridium botulinum progenitor M complex of type e

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Eswaramoorthy, Subramaniam ^a   Sun, Jingchuan ^a   Li, Huilin ^a,c   Singh, Bal Ram ^b   Swaminathan, Subramanyam ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b Botulinum Research Center   (Canada)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; BOTULINUM TOXIN; BOTULINUM TOXIN E; SOLUTION AND SOLUBILITY;

CHEMISTRY; CLOSTRIDIUM BOTULINUM; METABOLISM; MOLECULAR MODEL; PH; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; SOLUTION AND SOLUBILITY; ULTRASTRUCTURE; X RAY CRYSTALLOGRAPHY;

ACIDS; BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; CRYSTALLOGRAPHY, X-RAY; HYDROGEN-ION CONCENTRATION; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; SOLUTIONS;

EID: 84949591252     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17795     Document Type: Article

References (24)

1. Hatheway, C. L. Clostridium botulinum and other clostridia that produce botulinum neurotoxin. in Clostridium botulinum-ecology and control in foods (eds Hanschild, A. H. W. & Dodds, K. L.) 3-20 (Marcel Dekker Inc., New York, 1992).
2. Montecucco, C., Papini, E. & Schiavo, G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 346, 92-98 (1994).
3. Schiavo, G., Matteoli, M. & Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717-766 (2000).
4. Schantz, E. J. & Spero, L. Molecular size of Cl. botulinum toxins. In Botulism 1966 (eds Ingram, M. & Roberts, T. A.) 296-301 (Chapman and Hall, London, 1967).
5. Inoue, K. et al. Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 64, 1589-94 (1996).
6. Li, B., Qian, X., Sarkar, H. K. & Singh, B. R. Molecular characterization of type E Clostridium botulinum and comparison to other types of Clostridium botulinum. Biochim. Biophys. Acta 1395, 21-27 (1998).
7. Singh, B .R. & Zhang, Z. Novel proteins within the type E botulinum neurotoxin complex. Vol. U.S. Patent No. 6,699,966 (ed. U.S. Patent No. 6, 966) (USA, 2004).
8. Ohyama, T. et al. Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16. Microbio. Immunol. 39, 457-465 (1995).
9. Nakajima, N. et al. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873. Microbiol. Immunol. 42, 599-605 (1998).
10. Sugii, S., Ohishi, I. & Sakaguchi, G. Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect. Immun. 16, 910-914 (1977).
11. Gu, S. et al. Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science and Justice 335, 928-929 (2012).
12. Benefield, D. A., Dessain, S. K., Shine, N., Ohi, M. D. & Lacy, D. B. Molecular assembly of botulinum neurotoxin progenitor complexes. Proc. Natl. Acad. Sci. 110, 5630-5635 (2013).
13. Lee, K. et al. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog. 9, 1-13 (2013).
14. Kumaran, D. et al. Domain organization in Clostridium botulinum neurotoxin type E is unique: Its implication in faster translocation. J. Mol. Biol. 386, 233-245 (2009).
15. Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R. & Stevens, R. C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5, 898-902 (1998).
16. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality for assessing the accuracy of protein structures. J. Appl. Crystallogr. 26, 283-291 (1993).
17. Miyashita, S.-I., Sagane, Y., Niwa, K. & Watanabe, T. Transport of the botulinum neurotoxin-Associating protein, nontoxic nonhemagglutinin, across the rat small intestinal epithelial cell monolayer. FEMS Microbiol. Lett. 346, 73-80 (2013).
18. Breidenbach, M. A. & Brunger, A. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432, 925-929 (2004).
19. Kukreja, R. V. & Singh, B. R. Comparative role of neurotoxin-Associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E. Biochemistry 46, 14316-24 (2007).
20. Sagane, Y. et al. Small-Angle X-ray scattering reveals structural dynamics of the botulinum neurotoxin associating protein, nontoxic nonhemagglutinin. Biochem. Biophys. Res. Commun. 425, 256-260 (2012).
21. Singh, B. R., Foley, J. & Lafontaine, C. Physicochemical and immunological characterization of the type E botulinum neurotoxin binding protein purified from Clostridium botulinum. J Protein Chem 14, 7-18 (1995).
22. Gimenez, J. & Sugiyama, H. Simplified purification method for clostridium botulinum type E toxin. Applied Environmental Microbiology 53, 2827-2830 (1987).
23. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
24. CCP4. CCP4 Suite: programs for protein crystallography. Acta Crystallogr. D50, 760-763 (1994).